Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 13, 2025

Total Value ($000): $433,218 (100.0% shares, 0.0% debt)

Holdings (7)

MDXG MIMEDX GROUP, INC. 62.6%

Value ($000) $271,238 Shares 28,195,249 Est. Cost $7.32 Unrealized +6.4%

BVS BIOVENTUS 31.6%

Value ($000) $136,724 Shares 13,021,324 Est. Cost $13.37 Unrealized -11.5%

TELA TELA BIO, INC. 2.9%

Value ($000) $12,415 Shares 4,110,709 Est. Cost $11.82 Unrealized -76.2%

EYPT EYEPOINT PHARMACEUTICALS INC 2.0%

Value ($000) $8,715 Shares 1,169,857 Est. Cost $4.68 Unrealized +98.8%

MNOV MEDICINOVA INC 0.5%

Value ($000) $2,322 Shares 1,105,941 Est. Cost $2.95 Unrealized -33.8%

— REVANCE THERAPEUTICS INC 0.3%

Value ($000) $1,390 Shares 457,085 Est. Cost $31.50 Unrealized —

— VENUS CONCEPT, INC. 0.1%

Value ($000) $414 Shares 1,089,190 Est. Cost $0.69 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	28,195,249	$271,238	62.6%	$7.32	+6.4%	COM	602496101
BVS	BIOVENTUS	13,021,324	$136,724	31.6%	$13.37	-11.5%	COM CL A	09075A108
TELA	TELA BIO, INC.	4,110,709	$12,415	2.9%	$11.82	-76.2%	COM	872381108
EYPT	EYEPOINT PHARMACEUTICALS INC	1,169,857	$8,715	2.0%	$4.68	+98.8%	COM NEW	30233G209
MNOV	MEDICINOVA INC	1,105,941	$2,322	0.5%	$2.95	-33.8%	COM NEW	58468P206
—	REVANCE THERAPEUTICS INC	457,085	$1,390	0.3%	$31.50	—	COM	761330109
—	VENUS CONCEPT, INC.	1,089,190	$414	0.1%	$0.69	—	COM	92332W204